Dirk Kuypers

24.0k total citations · 2 hit papers
352 papers, 16.0k citations indexed

About

Dirk Kuypers is a scholar working on Transplantation, Surgery and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Dirk Kuypers has authored 352 papers receiving a total of 16.0k indexed citations (citations by other indexed papers that have themselves been cited), including 213 papers in Transplantation, 105 papers in Surgery and 79 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Dirk Kuypers's work include Renal Transplantation Outcomes and Treatments (213 papers), Pharmacological Effects and Toxicity Studies (77 papers) and Organ Transplantation Techniques and Outcomes (69 papers). Dirk Kuypers is often cited by papers focused on Renal Transplantation Outcomes and Treatments (213 papers), Pharmacological Effects and Toxicity Studies (77 papers) and Organ Transplantation Techniques and Outcomes (69 papers). Dirk Kuypers collaborates with scholars based in Belgium, United States and Germany. Dirk Kuypers's co-authors include Maarten Naesens, Yves Vanrenterghem, Pieter Evenepoel, Minnie Sarwal, Kathleen Claes, Hylke de Jonge, Evelyne Lerut, Bert Bammens, Bart Maes and Björn Meijers and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Dirk Kuypers

341 papers receiving 15.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Calcineurin Inhibitor Nephrotoxicity

2009 1.1k citations Maarten Naesens, Dirk Kuypers et al. profile →
Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients

2023 95 citations Ajit P. Limaye, Klemens Budde et al. JAMA profile →

Peers

Countries citing papers authored by Dirk Kuypers

Since Specialization

Citations

This map shows the geographic impact of Dirk Kuypers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Kuypers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Kuypers more than expected).

Fields of papers citing papers by Dirk Kuypers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dirk Kuypers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Kuypers. The network helps show where Dirk Kuypers may publish in the future.

Co-authorship network of co-authors of Dirk Kuypers

This figure shows the co-authorship network connecting the top 25 collaborators of Dirk Kuypers. A scholar is included among the top collaborators of Dirk Kuypers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dirk Kuypers. Dirk Kuypers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	STEADFAST Study Update: A Phase 1/2 Clinical Trial of Regulatory T Cells Expressing a Chimeric Antigen Receptor Directed Towards HLA-A2 in Renal Transplantation 2025 ·American Journal of Transplantation ·Katharina Schreeb, (unknown), Claire Chapman, (unknown), Yanmei Lu, (unknown), Melissa Chen, Dirk Kuypers, Jan‐Stephan Sanders, (unknown), Dennis A. Hesselink, Paul Harden	0
2	The impact of the Banff v-lesion on rejection classification and outcomes: Insights from a multicenter study 2025 ·American Journal of Transplantation ·(unknown), Maarten Coemans, Priyanka Koshy, Thibaut Vaulet, (unknown), (unknown), (unknown), Valérie Dubois, Marie‐Paule Emonds, Dirk Kuypers, Angelica Pagliazzi, Maud Rabeyrin, Aleksandar Senev, Irina Scheffner, (unknown), Olivier Thaunat, Candice Roufosse, Wilfried Gwinner, Maarten Naesens	1
3	Sensitive HLA antibody testing and the risk of antibody‐mediated rejection and graft failure 2024 ·HLA ·(unknown), Jasper Callemeyn, Maarten Coemans, (unknown), Priyanka Koshy, Dirk Kuypers, Aleksandar Senev, Anat R. Tambur, Elisabet Van Loon, (unknown), Maarten Naesens, Marie‐Paule Emonds	1
4	An observational cohort study examined the change point of kidney function stabilization in the initial period after transplantation 2024 ·Kidney International ·(unknown), Maarten Coemans, Soufian Meziyerh, (unknown), Marie‐Paule Emonds, (unknown), Jesper Kers, Dirk Kuypers, Irina Scheffner, Aleksandar Senev, Elisabet Van Loon, (unknown), Aiko P. J. de Vries, Geert Verbeke, Maarten Naesens	0
5	Benefits of Living Over Deceased Donor Kidney Transplantation in Elderly Recipients. A Propensity Score Matched Analysis of a Large European Registry Cohort 2024 ·Transplant International ·Néstor Toapanta, Jordi Comas, Ignacio Revuelta, Anna Manonelles, Carme Facundo, María José Pérez‐Sáez, A. Vilà, Emma Arcos, Jaume Tort, Magali Giral, Maarten Naesens, Dirk Kuypers, Anders Åsberg, Francesc Moreso, Oriol Bestard	1
6	Leukopenia in autosomal dominant polycystic kidney disease: a single-center cohort of kidney transplant candidates with post-transplantation follow-up 2023 ·Clinical Kidney Journal ·(unknown), Elisabet Van Loon, Maarten Coemans, Isabelle Meyts, Rudi Vennekens, Dirk Kuypers, Djalila Mekahli, Bert Bammens	1
7	Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients breakdown → 2023 ·JAMA ·Ajit P. Limaye, Klemens Budde, Atul Humar, Flavio Vincenti, Dirk Kuypers, Robert Carroll, Nicole Stauffer, Yoshihiko Murata, Julie Strizki, Valerie Teal, Christopher L. Gilbert, Barbara Haber	95
8	SARS‐CoV‐2 vaccine antibody response and breakthrough infections in transplant recipients 2023 ·Journal of Medical Virology ·(unknown), (unknown), Kris Bogaerts, Pieter Vermeersch, Katrien Lagrou, Geert Molenberghs, Filip Rega, Laurens J. Ceulemans, Dirk Van Raemdonck, Ina Jochmans, Diethard Monbaliu, Jacques Pirenne, Tim Vanuytsel, Pieter Gillard, Hélène Schoemans, Johan Van Cleemput, Dirk Kuypers, Robin Vos, Frederik Nevens, Jef Verbeek	10
9	Biological pathways and comparison with biopsy signals and cellular origin of peripheral blood transcriptomic profiles during kidney allograft pathology 2022 ·Kidney International ·Elisabet Van Loon, Baptiste Lamarthée, Henriëtte de Loor, Amaryllis H. Van Craenenbroeck, Sophie Brouard, Richard Danger, Magali Giral, Jasper Callemeyn, Claire Tinel, (unknown), Priyanka Koshy, Ben Sprangers, Dirk Kuypers, Wilfried Gwinner, Dany Anglicheau, Pierre Marquet, Maarten Naesens	15
10	Patterns of renal osteodystrophy 1 year after kidney transplantation 2021 ·Nephrology Dialysis Transplantation ·Hanne Skou Jørgensen, Geert J. Behets, Bert Bammens, Kathleen Claes, Björn Meijers, Maarten Naesens, Ben Sprangers, Dirk Kuypers, Patrick C. D’Haese, Pieter Evenepoel	12
11	Assessment of the Utility of Kidney Histology as a Basis for Discarding Organs in the United States: A Comparison of International Transplant Practices and Outcomes 2020 ·Journal of the American Society of Nephrology ·Peter P. Reese, Olivier Aubert, Maarten Naesens, Edmund Huang, Vishnu S. Potluri, Dirk Kuypers, Antoine Bouquegneau, Gillian Divard, Marc Raynaud, Yassine Bouatou, Ashley Vo, Denis Glotz, Christophe Legendre, Carmen Lefaucheur, Stanley C. Jordan, Jean‐Philippe Empana, Xavier Jouven, Alexandre Loupy	49
12	Disseminated histoplasmosis in a kidney liver transplant patient from a non-endemic area: A diagnostic challenge 2020 ·IDCases ·(unknown), Amaryllis H. Van Craenenbroeck, Katrien Lagrou, Christophe M. Deroose, Xavier Sagaert, Albert Wolthuis, Eric Van Wijngaerden, Dirk Kuypers	3
13	Pretransplant 4β‐hydroxycholesterol does not predict tacrolimus exposure or dose requirements during the first days after kidney transplantation 2017 ·British Journal of Clinical Pharmacology ·Thomas Vanhove, Mahmoud Hasan, Pieter Annaert, Stefan Oswald, Dirk Kuypers	8
14	Invasive aspergillosis after kidney transplantation: a monocentric retrospective experience 2015 ·Lirias (KU Leuven) ·Line Heylen, Johan Maertens, Bert Bammens, (unknown), Pieter Evenepoel, Björn Meijers, Maarten Naesens, Dirk Kuypers, Ben Sprangers	1
15	LineageProfiler: A Novel Informatics Tool for Unraveling Transplant Injury 2013 ·American Journal of Transplantation ·Maarten Naesens, Tara K. Sigdel, Nathan Salomonis, Silke Roedder, (unknown), Matthew J. Vitalone, Dirk Kuypers, Evelyne Lerut, Minnie Sarwal	1
16	How Delayed Graft Function Impacts Exposure to Mycophenolic Acid in Patients After Renal Transplantation 2011 ·Therapeutic Drug Monitoring ·Teun van Gelder, Hélio Tedesco‐Silva, Johan W. de Fijter, Klemens Budde, Dirk Kuypers, Richard D. Mamelok, Victor W. Armstrong, Michael Oellerich	12
17	Opportunities to Optimize Tacrolimus Therapy in Solid Organ Transplantation: Report of the European Consensus Conference 2009 ·Therapeutic Drug Monitoring ·Pierre Wallemacq, Victor W. Armstrong, Merçè Brunet, Vincent Haufroid, David W. Holt, A. E. Johnston, Dirk Kuypers, Yannick Le Meur, Pierre Marquet, Michael Oellerich, Éric Thervet, (unknown), N. Undre, Lutz T. Weber, Ian S Westley, Michel Mourad	362
18	Polyomavirus associated nephropathy type B and lacte acute cellular rejection grade 1: morphologically indistinguishable or not 2009 ·Transplant International ·(unknown), Maarten Naesens, Yves Vanrenterghem, Dirk Kuypers, Evelyne Lerut	1
19	Adjuvant low dose cidofovir therapy and reduction of immunosuppression for BK polyomavirus interstitial nephritis (BKVIN) in renal recipients 2005 ·Nephrology Dialysis Transplantation ·Dirk Kuypers, Evelyne Lerut, Pieter Evenepoel, Robert Snoeck, Yves Vanrenterghem	1
20	Long-term pharmacokinetic characteristics of the novel combination of tacrolimus and rapamycin in renal transplant recipients 2002 ·Journal of the American Society of Nephrology ·Dirk Kuypers, Pieter Evenepoel, Bart Maes, Yves Vanrenterghem	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact